Elanco Animal Health Share Price Today
(NASDAQ: ELAN)

Name: Elanco Animal Health Share Price Today (NASDAQ: ELAN) - Elanco Animal Health Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Elanco Animal Health share price is $10.85 & ₹944.66 as on 6 Mar 2025, 2.30 'hrs' IST

$10.85

▲

0.05

(0.46%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Elanco Animal Health share price in Dollar and Rupees. Guide to invest in Elanco Animal Health stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Elanco Animal Health, along with analyst recommendations, forecasts, and comprehensive financials.

Elanco Animal Health share price movements

Today's Low: $10.73
Today's High: $11.04
$10.85
1.1%
Downside
Day's Volatility :2.81%
Upside
1.72%
52 Weeks Low: $10.20
52 Weeks High: $18.80
$10.85
5.99%
Downside
52 Weeks Volatility :45.74%
Upside
42.29%

Elanco Animal Health (ELAN) Returns

Period	Elanco Animal Health Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-10.48%	3.7%	0.0%
6 Months	-29.32%	-2.8%	0.0%
1 Year	-32.4%	2.5%	0.0%
3 Years	-58.01%	12.9%	-11.6%

Elanco Animal Health (ELAN) Key Statistics

in dollars & INR

Previous Close	$10.8
Open	$10.82
Today's High	$11.04
Today's Low	$10.7302
Market Capitalization	$5.3B
Today's Volume	$3.4M
52 Week High	$18.8
52 Week Low	$10.2
Revenue TTM	$4.4B
EBITDA	$879.0M
Earnings Per Share (EPS)	$0.65
PE Ratio	16.62
Profit Margin	7.61%
Quarterly Earnings Growth YOY	-0.71%
Return On Equity TTM	5.49%

How to invest in Elanco Animal Health Stock (ELAN) from India?

It is very easy for Indian residents to invest directly in Elanco Animal Health from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Elanco Animal Health stock in both Indian Rupees (INR) and US Dollars (USD). Search for Elanco Animal Health or ELAN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Elanco Animal Health or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Elanco Animal Health shares which would translate to 0.080 fractional shares of Elanco Animal Health as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Elanco Animal Health, in just a few clicks!

Returns in Elanco Animal Health (ELAN) for Indian investors in Rupees

The Elanco Animal Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Elanco Animal Health investment value today

Current value as on today

₹72,666

Returns

₹27,334

(-27.33%)

Returns from Elanco Animal Health Stock

₹32,399 (-32.4%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Elanco Animal Health (ELAN)

-29%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Elanco Animal Health Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Elanco Animal Health

Dodge & Cox
16.82%
PRIMECAP Management Company
10.34%
Vanguard Group Inc
9.86%
FMR Inc
8.13%
BlackRock Inc
5.03%
Black Creek Investment Management Inc
4.13%

Analyst Recommendation on Elanco Animal Health

Buy

66%Buy

28%Hold

4%Sell

Based on 21 Wall street analysts offering stock ratings for Elanco Animal Health(by analysts ranked 0 to 5 stars)

Based on 21 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Elanco Animal Health Stock (ELAN)

What analysts predicted

Upside of 45.16%

Target:

$15.75

Current:

$10.85

Insights on Elanco Animal Health Stock (Ticker Symbol: ELAN)

Price Movement
In the last 6 months, ELAN stock has moved down by -28.1%
Decreasing Revenue
Revenue is down for the last 4 quarters, 1.20B → 1.02B (in $), with an average decrease of 5.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 364.0M → -8.0M (in $), with an average decrease of 102.2% per quarter
ELAN vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 98.7% return, outperforming this stock by 131.1%
ELAN vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.1% return, outperforming this stock by 199.3%
Price to Sales
ForELAN every $1 of sales, investors are willing to pay $1.2, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

ELAN Elanco Animal Health Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$3.1B	↑ 0.14%
Net Income	$67.9M	↓ 21.5%
Net Profit Margin	2.21%	↓ 0.61%

	FY20	Y/Y Change
Revenue	$3.3B	↑ 6.59%
Net Income	$-560.1M	↓ 924.89%
Net Profit Margin	-17.11%	↓ 19.32%

	FY21	Y/Y Change
Revenue	$4.8B	↑ 45.57%
Net Income	$-472.0M	↓ 15.73%
Net Profit Margin	-9.91%	↑ 7.2%

	FY22	Y/Y Change
Revenue	$4.4B	↓ 7.28%
Net Income	$-74.0M	↓ 84.32%
Net Profit Margin	-1.67%	↑ 8.24%

	FY23	Y/Y Change
Revenue	$4.4B	↓ 0.02%
Net Income	$-1.2B	↑ 1563.51%
Net Profit Margin	-27.87%	↓ 26.2%

	FY24	Y/Y Change
Revenue	$4.4B	↑ 0.5%
Net Income	$338.0M	↓ 127.46%
Net Profit Margin	7.61%	↑ 35.48%

	Q3 FY23	Q/Q Change
Revenue	$1.1B	↑ 1.04%
Net Income	$-1.1B	↑ 1029.9%
Net Profit Margin	-102.62%	↓ 93.44%

	Q4 FY23	Q/Q Change
Revenue	$1.0B	↓ 3.09%
Net Income	$-141.0M	↓ 87.14%
Net Profit Margin	-13.62%	↑ 89.0%

	Q1 FY24	Q/Q Change
Revenue	$1.2B	↑ 16.43%
Net Income	$32.0M	↓ 122.7%
Net Profit Margin	2.66%	↑ 16.28%

	Q2 FY24	Q/Q Change
Revenue	$1.2B	↓ 1.74%
Net Income	$-50.0M	↓ 256.25%
Net Profit Margin	-4.22%	↓ 6.88%

	Q3 FY24	Q/Q Change
Revenue	$1.0B	↓ 13.01%
Net Income	$364.0M	↓ 828.0%
Net Profit Margin	35.34%	↑ 39.56%

	Q4 FY24	Q/Q Change
Revenue	$1.0B	↓ 0.97%
Net Income	$-8.0M	↓ 102.2%
Net Profit Margin	-0.78%	↓ 36.12%

	FY19	Y/Y Change
Profit	$1.6B	↑ 7.21%

	FY20	Y/Y Change
Profit	$1.6B	↑ 0.37%

	FY21	Y/Y Change
Profit	$2.6B	↑ 63.75%

	FY22	Y/Y Change
Profit	$2.5B	↓ 4.79%

	FY23	Y/Y Change
Profit	$1.9B	↓ 22.63%

	FY24	Y/Y Change
Profit	$1.9B	↓ 1.5%

	Q3 FY23	Q/Q Change
Profit	$581.0M	↓ 6.74%

	Q4 FY23	Q/Q Change
Profit	$519.0M	↓ 10.67%

	Q1 FY24	Q/Q Change
Profit	$690.0M	↑ 32.95%

	Q2 FY24	Q/Q Change
Profit	$558.0M	↓ 19.13%

	Q3 FY24	Q/Q Change
Profit	$405.0M	↓ 27.42%

	Q4 FY24	Q/Q Change
Profit	$389.0M	↓ 3.95%

	FY19	Y/Y Change
Operating Cash Flow	$224.1M	↓ 54.01%
Investing Cash Flow	$-234.8M	↑ 84.88%
Financing Cash Flow	$-304.8M	↑ 765.91%

	FY20	Y/Y Change
Operating Cash Flow	$-41.0M	↓ 118.3%
Investing Cash Flow	$-4.8B	↑ 1935.43%
Financing Cash Flow	$5.0B	↓ 1725.3%

	FY21	Y/Y Change
Operating Cash Flow	$483.0M	↓ 1278.05%
Investing Cash Flow	$-530.0M	↓ 88.91%
Financing Cash Flow	$210.0M	↓ 95.76%

	FY22	Y/Y Change
Operating Cash Flow	$452.0M	↓ 6.42%
Investing Cash Flow	$-179.0M	↓ 66.23%
Financing Cash Flow	$-549.0M	↓ 361.43%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$198.0M	↑ 224.59%
Investing Cash Flow	$-36.0M	↓ 16.28%
Financing Cash Flow	$-157.0M	↓ 502.56%

Elanco Animal Health Technicals Summary

Sell

Neutral

Buy

Elanco Animal Health is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Elanco Animal Health (ELAN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Elanco Animal Health Inc	-5.73%	-29.32%	-32.4%	-58.01%	-54.58%
Intra-cellular Therapies, Inc.	3.38%	81.15%	98.68%	146.46%	588.66%
Haleon Plc Spon Ads	10.71%	2.13%	26.53%	42.24%	42.24%
Zoetis Inc.	-3.04%	-10.5%	-9.01%	-11.21%	28.74%
Neurocrine Biosciences Inc.	-25.31%	-6.07%	-13.91%	29.45%	28.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Elanco Animal Health Inc	16.62	16.62	1.15	0.86	0.05	0.01	NA	12.33
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.35	26.35	1.92	0.36	0.09	0.04	0.02	1.8
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	34.6	34.6	0.27	6.44	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Elanco Animal Health Inc	Buy	$5.3B	-54.58%	16.62	7.61%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.66%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$47.7B	42.24%	26.35	12.84%
Zoetis Inc.	Buy	$76.1B	28.74%	31.17	26.86%
Neurocrine Biosciences Inc.	Buy	$11.4B	28.72%	34.6	14.49%

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Organization	Elanco Animal Health
Employees	9000
CEO	Mr. Jeffrey N. Simmons
Industry	Process Industries

Management People of Elanco Animal Health

Name	Title
Mr. Jeffrey N. Simmons	President, CEO & Director
Mr. Todd S. Young J.D.	Executive VP & CFO
Dr. Ramiro Martin Cabral	Executive Vice President of Elanco International
Dr. Ellen de Brabander Ph.D.	Executive Vice President of Research, Development & Regulatory Affairs
Mr. Timothy J. Bettington	Executive Vice President of Corporate Strategy & Market Development
Mr. James M. Meer	Senior VP & Chief Accounting Officer
Mr. Chris Keeley	Senior VP & Chief Information Officer
Mr. David S. Kinard	Executive Vice President of Human Resources, Corporate Communications & Administration
Ms. Shiv O'Neill	Executive Vice President, General Counsel & Corporate Secretary
Mr. Larbi Van Lier	Senior Vice President of Asia

Important FAQs about investing in ELAN Stock from India :

What is Elanco Animal Health share price today?

Elanco Animal Health share price today stands at $10.85, Open: $10.82 ; Previous Close: $10.80 ; High: $11.04 ; Low: $10.73 ; 52 Week High: $18.80 ; 52 Week Low: $10.20.

The stock opens at $10.82, after a previous close of $10.80. The stock reached a daily high of $11.04 and a low of $10.73, with a 52-week high of $18.80 and a 52-week low of $10.20.

Can Indians buy Elanco Animal Health shares?

Yes, Indians can invest in the Elanco Animal Health (ELAN) from India.

With INDmoney, you can buy Elanco Animal Health at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Elanco Animal Health at zero transaction cost.

How can I buy Elanco Animal Health shares from India?

It is very easy to buy Elanco Animal Health from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Elanco Animal Health (ELAN) be purchased?

Yes, you can buy fractional shares of Elanco Animal Health with INDmoney app.

What are the documents required to start investing in Elanco Animal Health stocks?

To start investing in Elanco Animal Health, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.